During 2018 Q3 the big money sentiment decreased to 1.24. That’s change of 2.51, from 2018Q2’s 3.75. 17 investors sold all, 25 reduced holdings as Sientra, Inc. ratio is negative. 32 grew holdings while 20 funds acquired holdings. Funds hold 24.04 million shares thus 50.28% less from 2018Q2’s 48.35 million shares.
Ubs Asset Mgmt Americas Inc, a Illinois-based fund reported 639,790 shs. Friess Assocs Lc holds 0.05% or 32,210 shs in its capital. Granahan Invest Management Ma holds 0.4% of its capital in Sientra, Inc. (NASDAQ:SIEN) for 305,116 shs. Alliancebernstein Ltd Partnership holds 0% in Sientra, Inc. (NASDAQ:SIEN) or 21,500 shs. The Pennsylvania-based Emerald Mutual Fund Advisers Tru has invested 0.06% in Sientra, Inc. (NASDAQ:SIEN). Mutual Of America Cap invested in 0.02% or 61,970 shs. Barclays Pcl invested in 31,764 shs. Tiaa Cref Inv Management Ltd Liability Corp reported 0% stake. First Manhattan owns 1,200 shs for 0% of their capital. Dorsey Wright holds 0% or 765 shs in its capital. Thompson Davis & Company reported 3,250 shs. Vanguard Group Inc Inc owns 1.02M shs. Timpani Mgmt Lc holds 42,037 shs or 0.29% of its capital. Parametric Port Associates Ltd Liability Com holds 125,000 shs or 0% of its capital. United Service Automobile Association has 0.01% invested in Sientra, Inc. (NASDAQ:SIEN) for 237,529 shs.
Sientra, Inc. had 1 sale and 0 insider buys since November 6, 2018. This’s net activity of $1.93 million.
Sientra, Inc. (NASDAQ:SIEN)’s earnings report is awaited on March, 12., according to Zacks. The EPS diference is $0.24 or 26.09 % up from last years number. Previous year: $-0.92; Analysts forcast: $-0.68. Last quarter $-0.72 EPS was reported. Analysts sees -5.56 % EPS growth this quarter. SIEN touched $11.46 during the last trading session after $0.39 change.Sientra, Inc. has 964,017 shares volume, 79.15% up from normal. SIEN is uptrending and has moved 28.60% since March 2, 2018. SIEN outperformed the S&P500 by 28.60%.
Sientra, Inc., a medical aesthetics company, develops and sells medical aesthetics products to plastic surgeons in the United States.The firm is worth $327.75 million. The firm offers silicone gel breast implants for use in breast augmentation and breast reconstruction procedures; and breast tissue expanders.Currently it has negative earnings. It also provides body contouring products; facial and nasal implants; scar management products under the bioCorneum and Silishield brand names; saline-filled breast implant sizers to identify the correct style and size of implants; and non-breast tissue expanders for expanding tissue and skin surface area for burn care and other reconstructive use.
For more Sientra, Inc. (NASDAQ:SIEN) news posted recently go to: Globenewswire.com, Globenewswire.com, Globenewswire.com, Nasdaq.com or Seekingalpha.com. The titles are as follows: “Sientra® to Release Third Quarter 2018 Financial Results on November 6, 2018 – GlobeNewswire” posted on October 23, 2018, “Sientra Announces Preliminary Unaudited Fourth Quarter 2018 Net Sales and Appointment of Aesthetic Industry Veteran to Board of Directors – GlobeNewswire” on January 07, 2019, “Market Trends Toward New Normal in Micron Technology, Harris, Sientra, Noble, Amphastar Pharmaceuticals, and CECO Environmental — Emerging Consolidated Expectations, Analyst Ratings – GlobeNewswire” with a publish date: February 26, 2019, “Notable Friday Option Activity: VMW, MTN, SIEN – Nasdaq” and the last “Tractor Supply Is A Buy – Cramer’s Lightning Round (8/8/18) – Seeking Alpha” with publication date: August 09, 2018.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.